A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT)
A Randomized Controlled Non-inferiority Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of Subjects with Stenotic, Restenotic or Occlusive Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
Sponsor: ID3 Medical
A NA clinical study on Peripheral Arterial Disease, this trial is ongoing. The trial is conducted by ID3 Medical and has accumulated 9 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Nov 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 4 earlier versions
-
Oct 2021 — Jun 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2021 — Oct 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Apr 2019 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ID3 Medical
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalst, Belgium , Antwerp, Belgium , Avignon, France , Bonheiden, Belgium , Bordeaux, France , Dendermonde, Belgium , Genk, Belgium , Graz, Austria , Lausanne, Switzerland , Paris, France and 4 more locations